Abstract
We recently encountered a 6-year-old girl with a malignant phyllodes tumor of the breast. The patient’s mother noticed a tumor on the right breast of her first daughter at 8 months after from her birth. The baby was brought to the Second Department of Surgery, University of Tokushima, at age 20 months. We recommended removal of the 3.5 × 2.9 cm tumor in the right breast, but it was not done. Next, she visited our department at 6 years of age because the tumor had gradually enlarged, reaching a size of 4.3 × 4.0 cm. She underwent excisional resection of the tumor, and the tumor was diagnosed as a malignant phyllodes tumor of the breast coexisting with a borderline phyllodes tumor. To our knowledge, this is the youngest reported case of a malignant phyllodes tumor of the breast. Moreover, the malignant lesion was positive for estrogen receptor (ER) and showed strong proliferating cell nuclear antigen (PCNA) staining. On the other hand, the borderline part was negative for ER and showed weak PCNA staining. Thus, in the present case, the expression of ER, the exposure to estrogen (for example, the mother’s estrogen during gestation) and increase in the proliferation rate may have played important roles in the mechanism of the transformation of the phyllodes tumor.
Similar content being viewed by others
Abbreviations
- ER:
-
Estrogen receptor
- PCNA:
-
Proliferating cell nuclear antigen
References
Norris HJ, Taylor HB: Relationship of the histologic appearance of behavior of cystosarcoma phyllodes; Analysis of ninety-four cases.Cancer 20:2090–2099, 1967.
Stromberg GV, Golladay ES: Cystosarcoma phyllodes in the adolescent female.J Pediatr Surg 13:423–426, 1978.
Salvadori B, Cusumand F, Bo RD,et al: Surgical treatment of phyllodes tumors of the breast.Cancer 63:2532–2536, 1989.
Palmer ML, De Risi DC, Peliken A,et al: Treatment options and recurrence potential for cystosarcoma phyllodes.Surg Gynecol Obstet 170:193–196, 1990.
El-Naggar AK, Ro JY, McLemore D,et al: DNA content and proliferative activity of cystosarcoma phyllodes of the tumor.Am J Clin Pathol 93:480–485, 1990.
Layfield LJ, Hart J, Neuwirth H: Relation between DNA ploidy and the clinical behavior of phyllodes tumors.Cancer 64:1486–1489, 1989.
Dyer NH, Bridger JE, Taylor RS: Cystosarcoma phyllodes.Br J Surg 53:450–455, 1966.
Hafner D, Mezger E, Wylie JH: Cystosarcoma phyllodes of the breast.Surg Gynecol Obstet 115:29–34, 1962.
Hajdu S, Espinosa MH, Robbins GF: Recurrent cystosarcoma phyllodes; A clinicopathologic study of 32 cases.Cancer 38:1402–1405, 1975.
Rao BR, Meyer JS, Fry CG: Most cystosarcoma phyllodes and fibroadenomas have progesterone receptor but lack estrogen receptor; Stroma-localization of progesterone receptor.Cancer 47:2016–2021, 1981.
Sasa M, Komaki K, Tuzuki H,et al: Tumor progression accompanied by increase in proliferation rate in breast cancer.J Surg Oncol 54:255–259, 1993.
WHO: Histological typing of breast tumors.Tumori 68:181–198, 1982.
Pietruszka M, Barnes L: Cystosarcoma phyllodes; A clinicopathologic analysis of 42 cases.Cancer 41:1974–1983, 1978.
McDivitt RW, Stewart FW, Berg JW: Tumors of the breast. In: Atlas of Tumor Pathology, 2nd Ser, fasc 2, Armed Forces Institute of Pathology, Washington, DC, 1968.
Landberg G, Roos G: Antibodies to proliferating cell nuclear antigen as S-phase probes in flow cytometric cell cycle analysis.Cancer Res 51:4570–4574, 1991.
Porton WM, Poortman J: Estrogen receptors in cystosarcoma phyllodes of the breast.Eur J Cancer Clin Oncol 17:1147–1148, 1981.
Author information
Authors and Affiliations
About this article
Cite this article
Sasa, M., Morimoto, T., Ii, K. et al. A malignant phyllodes tumor of the breast in a 6-year old girl. Breast Cancer 2, 71–75 (1995). https://doi.org/10.1007/BF02966899
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02966899